XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice (IRIS XPEDITION)

Seung-Jung Park

Status: Active, not recruiting

Conditions: Coronary Artery Disease; Percutaneous Transluminal Coronary Angioplasty

Treatments: Device: XIENCE Xpedition/Alpine/Sierra

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02042300

AMCCV2013-11

Details and patient eligibility

About

The purpose of this study is to evaluate effectiveness and safety of XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice

Enrollment: 4,000 patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 19 and more
• Intervention with XIENCE Xpedition or Alpine or Sierra everolimus eluting coronary stent
• Agreed with written informed consent form

Exclusion criteria

• Intervention with XIENCE Xpedition or Alpine or Sierra everolimus eluting coronary stent and other drug eluting stent at the same time
• Life expectancy of 1year and under
• Cardiac shock

Trial design

4,000 participants in 1 patient group

IRIS-Xpedition/Alpine/Sierra Cohort

Description:

XIENCE Xpedition/Alpine/Sierra

Treatment:

Device: XIENCE Xpedition/Alpine/Sierra